grant
Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays
Organization GUILD ASSOCIATES, INC.Location DUBLIN, UNITED STATESPosted 30 Sept 2025Deadline 29 Sept 2026
NIHUS FederalResearch GrantFY2025Anti-Retroviral AgentsAssayBioassayBiologicalBiological AssayBloodBlood Reticuloendothelial SystemBlood SampleBlood specimenContracting OpportunitiesContractorContractsDetectionDevicesDrugsMedicationPharmaceutical PreparationsPharmaciesPharmacy facilityPhaseSamplingTimeUrineanti-retroviralantiretroviral therapyantiretroviral treatmentaptamerbiologiccostdetection limitdrug adherencedrug compliancedrug/agentmedication adherencemedication compliancepoint of caresensor
Full Description
The Contractor, Guild Associates, Inc., aims to develop an electrochemical aptamer-based sensor device for simple, rapid, and low-cost detection and quantification of antiretroviral therapy (ART) drugs in urine and blood samples at the point-of-care (POC).
Grant Number: 75N95025C00009-0-9999-1
NIH Institute/Center: NIH
Principal Investigator: SCOTT ANGUS
Sign up free to get the apply link, save to pipeline, and set email alerts.
Sign up free →Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click